Teladoc Health, Inc. (TDOC) has 7 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $68K. Most recent filing: Sept. 14, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 14, 2026 filed Sept. 10, 2026 | DIVITA CHARLES III CHIEF EXECUTIVE OFFICER | — | +24,997 | +6% | No | |
|
|
||||||
| Sept. 1, 2026 | Grasher Michael F Chief Financial Officer | $0 | 239,616 | 0% | No | |
|
|
||||||
| Aug. 4, 2026 filed Aug. 3, 2026 | Anquillare Mark V Director | $0 | 37,425 | 0% | No | |
|
|
||||||
| July 6, 2026 filed July 1, 2026 | Catapano Joseph Ronald Chief Accounting Officer | — | +1,430 | +13% | No | |
|
|
||||||
| July 6, 2026 | Bliss Kelly President, U.S. Group Health | −$23,750 | 2,500 | −3% | Yes | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free